Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
RNAi Technology
RNAi
EDG-2 siRNA (h)
Supplier Images
Published Figures
EDG-2 siRNA (h)
EDG-2 siRNA (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(13)
Figures:
(12)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
EDG-2 siRNA (h)
Description
EDG-2 siRNA (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
EDG-2 siRNA (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$293.00
Supplier Page
View Company Product Page
Catalog Number
sc-43746
Quantity
10 µM
Species
human
NCBI Full Gene Name
lysophosphatidic acid receptor 1
NCBI Gene Aliases
EDG2, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1
Type
siRNA/dsRNA
Gene Name
lysophosphatidic acid receptor 1
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (13)
(1)
Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA
1
European journal of pharmacology
April 15, 2020
Olianas MC, Dedoni S, Onali P.
(2)
LPA
1/3
signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer
Biochimica et biophysica acta. Molecular and cell biology of lipids
October 1, 2018
Lin YC, Chen CC, Chen WM, Lu KY, Shen TL, Jou YC, Shen CH, Ohbayashi N, Kanaho Y, Huang YL,
et al
.
(3)
EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling
Oncotarget
September 12, 2017
Xu M, Liu Z, Wang C, Yao B, Zheng X.
weeks. Establishment of
EDG2
knockdown
cells The Short interference RNA (siRNA) sequences against
EDG2
(
sc-43746
) and the related scramble siRNA sequences (
sc-37007
) were both purchased from
Santa Cruz Biotechnology
.
(4)
Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells
Oncotarget
January 19, 2016
Zuckerman V, Sokolov E, Swet JH, Ahrens WA, Showlater V, Iannitti DA, Mckillop IH.
(5)
Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells
Biochemical and biophysical research communications
November 1, 2013
Lin CC, Lin CE, Lin YC, Ju TK, Huang YL, Lee MS, Chen JH, Lee H.
(6)
LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis
Biochimie
September 1, 2012
Windischhofer W, Huber E, Rossmann C, Semlitsch M, Kitz K, Rauh A, Devaney T, Leis HJ, Malle E.
specific for Egr-1 (catalogue number: SI00030709, Qiagen) or
LPA1
(
Edg-2
,
Santa Cruz
: catalogue number:
sc-43746
) or with a scrambled negative control siRNA (catalogue number:
1022076
,
Qiagen
). The siRNA
transfection
(7)
Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells
International journal of cancer
August 15, 2012
Chen RJ, Chen SU, Chou CH, Lin MC.
(8)
Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
August 1, 2012
Cai Q, Zhao Z, Antalis C, Yan L, Del Priore G, Hamed AH, Stehman FB, Schilder JM, Xu Y.
(9)
Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells
PloS one
January 1, 2012
Lin CE, Chen SU, Lin CC, Chang CH, Lin YC, Tai YL, Shen TL, Lee H.
(Invitrogen) for 24 h. After
transfection
, cells were diluted and selected with puromycin (0.25 µg/ml).
LPA1
(
sc-43746
), LPA3 (sh37088;
Santa Cruz Biotechnology
, Santa Cruz, CA, USA), LEDGF (5′-agacagcaugaggaagcgdtdt) and
(10)
Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways
The Biochemical journal
October 1, 2011
Zhao J, He D, Berdyshev E, Zhong M, Salgia R, Morris AJ, Smyth SS, Natarajan V, Zhao Y.
(11)
Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-alpha, interleukin-8, and monocyte chemoattractant protein-1 in human first-trimester trophoblasts: possible roles in angiogenesis and immune regulation
Endocrinology
January 1, 2010
Chen SU, Chou CH, Chao KH, Lee H, Lin CW, Lu HF, Yang YS.
(12)
Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta
Endocrinology
November 1, 2008
Chen SU, Lee H, Chang DY, Chou CH, Chang CY, Chao KH, Lin CW, Yang YS.
(13)
Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome
The Journal of clinical endocrinology and metabolism
March 1, 2008
Chen SU, Chou CH, Lee H, Ho CH, Lin CW, Yang YS.
<<
<
>
>>
Reviews
Be the First to Write a Review!
EDG-2 siRNA (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$293.00
Product Specs
Company Info
Citations
Reviews
Back To Top